共 123 条
- [1] Pienta KJ(2005)Advances in prostate cancer chemotherapy: a new era begins CA Cancer J Clin 5 300-318
- [2] Smith DC(2003)Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain J Clin Oncol 17 3335-3342
- [3] Ernst DS(2003)Weekly administration of docetaxel for symptomatic metastatic hormone-refractory prostate carcinoma Cancer 8 1627-1634
- [4] Tannock IF(2003)Clinical approaches to osseous metastases in prostate cancer Oncologist 2 161-173
- [5] Winquist EW(1996)Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points J Clin Oncol 6 1756-1764
- [6] Venner PM(2004)Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 15 1502-1512
- [7] Reyno L(2008)Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa Ann Oncol 10 1749-1753
- [8] Moore MJ(2004)Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer N Engl J Med 15 1513-1520
- [9] Gravis G(2001)Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial Ann Oncol 9 1259-1264
- [10] Bladou F(2000)Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor Cancer 3 516-522